Nantahala Capital Adds Stake in Viemed Healthcare; Analysts Adjust Ratings
Nantahala Capital Management acquired 632,445 Viemed Healthcare shares, while Wasatch, Geode, Arrowstreet, and Goldman Sachs also increased positions. Several analyst notes shifted ratings, including Weiss moving from buy to hold and Freedom Capital lowering to hold, alongside an outperform view and a $14.00 target. Analysts project 0.41 EPS for the fiscal year.